Business

iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

NASHVILLE, Tenn., March 20, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report fourth quarter 2025 financial results after the market closes on Thursday, March 26, 2026. iMDx will host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day. The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: iMDx Q4 2025 Earn

articleInsight Molecular Diagnostics Inc.March 20, 20261/company/insight-molecular-diagnostics-inc/news/imdx-to-release-fourth-quarter-2025-results-on-march-26-2026-and-attend-needham-virtual-healthcare-conference
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

About this update from Insight Molecular Diagnostics Inc.

[{"type":"image","alt":"Insight Molecular Diagnostics Inc.","displaySize":"","headline":null,"caption":"Insight Molecular Diagnostics Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":114,"url":"https://media.zenfs.com/en/globenewswire.com/0d7abfd3cc0e9f19d3f8615dce794ac4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ALKr_u67t7mZA65QeGXCrQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2MA--/https://media.zenfs.com/en/globenewswire.com/0d7abfd3cc0e9f19d3f8615dce794ac4","width":300,"height":114}},"lazy":false},{"type":"text","content":"NASHVILLE, Tenn., March 20, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report fourth quarter 2025 financial results after the market closes on Thursday, March 26, 2026. iMDx will host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day.","length":363,"tagName":"p"},{"type":"text","content":"The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: iMDx Q4 2025 Earnings Webinar.","length":167,"tagName":"p"},{"type":"text","content":"An archived replay will be available after the call concludes on iMDx’s website within the Investors/Events & Presentations section here.","length":141,"tagName":"p"},{"type":"text","content":"Attendance at 25th Annual Needham Virtual Healthcare Conference","length":63,"tagName":"p"},{"type":"text","content":"Separately, on April 15th, Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 25th Annual Needham Virtual Healthcare Conference, taking place from April 13-16, 2026.","length":206,"tagName":"p"},{"type":"text","content":"Event: 25th Annual Needham Virtual Healthcare ConferencePresentation Date: April 15, 2026Format: Virtual fireside chat Webcast: Click here","length":141,"tagName":"p"},{"type":"text","content":"iMDx management will also be conducting one-on-one meetings with investors at the conference. Investors wishing to book a meeting are encouraged to reach out to their Needham sales representative.","length":196,"tagName":"p"},{"type":"text","content":"About Insight Molecular Diagnostics Inc.Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize acce...

More updates from Insight Molecular Diagnostics Inc.

Molecular DiagnosticsHealthcare ConferenceAndrea James